Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
June 09, 2020
Around the world COVID-19 and the policy responses to it are causing unprecedented disruptions of life and wellbeing. As scientists and governments around the world race to develop a vaccine at scale, we take a look at what a portfolio approach entails and why it is so important.
CGD NOTES
June 04, 2020
Diagnostic testing is at the center of the policy debate around COVID-19 interventions in India. As of June 1, 2020, India had conducted approximately 3.8 million tests since it began testing in February, but many experts have noted that testing capacity is still drastically insufficient for the ne...
Blog Post
January 15, 2020
Poor quality medicines pose significant risks to global health. This blog responds to a recent report from the National Academies that out clear recommendations to global, national and agency level stakeholders which can help strengthen food and medical products regulatory systems in low- and middle...
CGD NOTES
December 12, 2019
New technology, better use of data, and entrepreneurial passion in improving distribution channels is reaching a critical mass with the potential to drive extraordinary improvements in availability, affordability, and quality of health products. Global health institutions can play a significant role...
Blog Post
September 25, 2017
The level of challenge faced by Jordan and Moldova on refugees and migration is remarkable: while Jordan has welcomed over a million Syrian refugees, Moldova has a migration outflow equivalent to a quarter of its population. Without the option of closing their borders, the scale of these m...
POLICY PAPERS
March 04, 2015
Donors play a significant role in funding medicines and other commodities in global health. Of the approximately US $28.2 billion spent by donors in 2010, approximately 40% went towards medicines, vaccines and other health commodities, mainly in sub-Saharan Africa. The efficiency of this spend is th...